Cannabis News

Organigram Holdings shared their financial results for their third quarter.

Organigram Holdings (TSXV:OGI; OTCQB:OGRMF) shared their financial results for their third quarter.
As quoted in the press release:

Organigram’s financial results for the quarter completed May 31, 2017 included expenses associated with the implementation of an industry leading quality assurance program (the “QA Program“). The QA Program was implemented to ensure that the Company produces the highest quality product available in the marketplace and in response to a previously announced voluntary recall of certain product produced in 2016.
As a result of Organigram’s increased focus on product quality and safety with the stated objective of establishing a leadership position in such regard within the industry, the Company focused on introducing product of the highest quality to the market. In practice, the program effectively identified product lots that were to be removed from inventory well before being introduced to the marketplace. The successful implementation of this program resulted in a reduction in inventory value for the quarter.
Organigram is pleased with the results and progress made during the quarter from an operational perspective and management is confident that these actions build the foundation for long-term success for the Company. This focus on product quality contributed to a 25% net increase in registered patients in Q3 when compared to Q2.

Click here to read the full press release.

Source: www.marketwired.com

Featured

MARKETS

Markets
TSX20101.38-389.63
TSXV691.17-21.32
DOW31490.07-1164.52
S&P 5003923.68-165.17
NASD11418.15-566.37
ASX7112.50+19.50

COMMODITIES

Commodities
Gold1816.41+1.83
Silver21.34-0.28
Copper4.15-0.03
Palladium1998.00-47.00
Platinum931.00-20.00
Oil108.06-1.53
Heating Oil3.56-0.01
Natural Gas8.14-0.23

DOWNLOAD FREE REPORTS

×